Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.7188
+0.0363 (5.32%)
At close: May 13, 2025, 4:00 PM
0.7300
+0.0112 (1.56%)
Pre-market: May 14, 2025, 8:37 AM EDT
Biofrontera Employees
As of December 31, 2024, Biofrontera had 93 total employees, including 92 full-time and 1 part-time employees. The number of employees increased by 8 or 9.41% compared to the previous year.
Employees
93
Change (1Y)
8
Growth (1Y)
9.41%
Revenue / Employee
$401,301
Profits / Employee
-$190,957
Market Cap
6.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 93 | 8 | 9.41% |
| Dec 31, 2023 | 85 | 4 | 4.94% |
| Dec 31, 2022 | 81 | 12 | 17.39% |
| Dec 31, 2021 | 69 | 13 | 23.21% |
| Dec 31, 2020 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BFRI News
- 7 days ago - Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025 - Accesswire
- 12 days ago - Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis - GlobeNewsWire
- 7 weeks ago - Biofrontera Inc. (BFRI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 2 months ago - Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk - GlobeNewsWire
- 2 months ago - Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025 - GlobeNewsWire
- 4 months ago - Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC) - GlobeNewsWire
- 5 months ago - Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market - GlobeNewsWire